| MolName | 3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-7-[[2-[(6,7-dihydroxy-4-oxochromene-3-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| MolecularFormula | C29H23N7O12S2 |
| Smiles | OC(Cn1nnnc1SCC(CSC1C2NC(C(c(cc3)ccc3O)NC(C3=COc(cc(c(O)c4)O)c4C3=O)=O)=O)=C(C(O)=O)N1C2=O)=O |
| InChI | InChI=1S/C29H23N7O12S2/c37-13-3-1-11(2-4-13)20(30-24(43)15-8-48-18-6-17(39)16(38)5-14(18)23(15)42)25(44)31-21-26(45)36-22(28(46)47)12(9-49-27(21)36)10-50-29-32-33-34-35(29)7-19(40)41/h1-6,8,20-21,27,37-39H,7,9-10H2,(H,30,43)(H,31,44)(H,40,41)(H,46,47) |
| InChIK | IZPIFKHYHHWRMA-UHFFFAOYSA-N |
| TotalMolweight | 725.671 |
| Molweight | 725.671 |
| MonoisotopicMass | 725.084613 |
| CLogP | -1.3875 |
| CLogS | -3.083 |
| H Acceptors | 19 |
| H Donors | 7 |
| TotalSurfaceArea | 480.62 |
| Relative PSA | 0.5305 |
| PolarSurfaceArea | 334.3 |
| Druglikeness | 7.6336 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.48 |
| Fragments | 1 |
| Non HAtoms | 50 |
| NonCHAtoms | 21 |
| Electronegative Atoms | 21 |
| StereoCenters | 3 |
| Rotatable Bond | 11 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 14 |
| Symmetricatoms | 2 |
| Amides | 3 |
| Aromatic Nitrogens | 4 |
| AcidicOxygens | 2 |
| StereoCon | unknown chirality |
Click to Load Molecule:
1 - 3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-7-[[2-[(6,7-dihydroxy-4-oxochromene-3-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 2 - 3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-7-[[2-[(6,7-dihydroxy-4-oxochromene-3-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid